Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CONDROITIN SULFATO ABAMED 400 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/CONDROITIN SULFATO ABAMED 400 MG CAPSULAS DURAS EFG

Approved

STANDARD

CONDROITIN SULFATO ABAMED 400 MG CAPSULAS DURAS EFG

Qualix Pharma S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 6, 2022
Approval ID: 42cf598805d58175
Company: Qualix Pharma S.L.
Type: Standard

Approval Details

Approval Id: 42cf598805d58175
Drug Cima Aemps Name: CONDROITIN SULFATO ABAMED 400 MG CAPSULAS DURAS EFG
Register Number: 87950
Holder Company Name: Qualix Pharma S.L.
Marketing Company Name: Qualix Pharma S.L.
Authorization Date: 2022-07-06
Dosage Form: CÁPSULA DURA
Dose: 400 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Qualix Pharma S.L.

Active Ingredients

CONDROITINA SULFATO SODIO

400 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 6, 2022

Approval ID

42cf598805d58175

Type

Standard

Back to CIMA-AEMPS Approvals